SELLAS Life Sciences
SLS
#6183
Rank
S$1.09 B
Marketcap
S$6.10
Share price
-8.46%
Change (1 day)
280.86%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2025 (TTM): -S$35.42 Million

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$40.4 Million, an increase over its 2023 earnings that were of -S$48.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$35.42 Million-12.31%
2024 -S$40.4 Million-16.78%
2023 -S$48.54 Million-9.73%
2022 -S$53.77 Million65.85%
2021 -S$32.42 Million48.95%
2020 -S$21.77 Million-1.31%
2019 -S$22.06 Million-44.65%
2018 -S$39.85 Million45.99%
2017 -S$27.3 Million-33.17%
2016 -S$40.85 Million-6.87%
2015 -S$43.86 Million-30.98%
2014 -S$63.55 Million46.52%
2013 -S$43.38 Million
2011 -S$21.53 Million
2008 -S$18.66 Million27.51%
2007 -S$14.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 449.52%๐Ÿ‡บ๐Ÿ‡ธ USA